R&D deduction capped by prescribed certification, while MEIS receipts and subsidiary investment loss were treated on their true legal character.

Following the 2016 amendment to section 35(2AB), weighted deduction for in-house R&D was confined to the expenditure quantified by the prescribed authority in Form 3CL, and no higher claim could be allowed. MEIS receipts were treated as capital receipts and therefore excluded from taxable income and from book profit adjustment under section 115JB in the absence of a specific statutory add-back. Loss on investment in a subsidiary, made for business purposes and commercial expediency, was accepted as a business loss rather than a capital loss, and the absence of a revised return did not bar the claim when raised in appeal.

---

---

Issues: (i) Whether weighted deduction under section 35(2AB) could be claimed on the full in-house research and development expenditure notwithstanding the quantum certified by the prescribed authority; (ii) whether MEIS receipts were capital in nature and therefore not includible in taxable income or book profit under section 115JB; (iii) whether loss on investment in a subsidiary company could be claimed as a business loss without revising the return; and (iv) whether such loss was a capital loss.

Issue (i): Whether weighted deduction under section 35(2AB) could be claimed on the full in-house research and development expenditure notwithstanding the quantum certified by the prescribed authority.

Analysis: The assessee's claim was examined in the context of the amendment to section 35(2AB) with effect from 01-04-2016, under which the prescribed authority was required to quantify the eligible expenditure in Form 3CL. The deduction was confined to the expenditure certified by the prescribed authority, and the Revenue authorities were not bound to allow a higher amount on the basis of the assessee's broader claim.

Conclusion: The restriction of weighted deduction to the amount certified by DSIR was upheld and the assessee failed on this issue.

Issue (ii): Whether MEIS receipts were capital in nature and therefore not includible in taxable income or book profit under section 115JB.

Analysis: The receipts were treated as capital receipts following the earlier coordinate bench view in the assessee's own case and the settled principle that export incentive receipts of this nature, when linked to promotion of industrial and export activity, assume the character of capital receipt. Once so characterised, they could not be brought to tax as revenue income, and they were also not liable to be added back to book profit under section 115JB in the absence of a specific statutory adjustment.

Conclusion: MEIS receipts were held to be capital in nature and the Revenue failed on this issue, including the MAT adjustment.

Issue (iii): Whether loss on investment in a subsidiary company could be claimed as a business loss without revising the return.

Analysis: The loss was considered in the light of the doctrine of commercial expediency and the established principle that investment in a subsidiary made to further business operations may give rise to a business loss rather than a capital loss. The absence of a revised return did not defeat the claim where the appellate authority could entertain the additional claim in accordance with law.

Conclusion: The claim was upheld as a business loss and the Revenue failed on this issue.

Issue (iv): Whether such loss was a capital loss.

Analysis: The nature of the investment and its business purpose were decisive. On the facts, the loss did not arise from acquisition or disposal of a capital asset in the capital field, but from an investment made for business purposes and commercial expediency.

Conclusion: The loss was not treated as a capital loss and the Revenue failed on this issue.

Final Conclusion: The assessee's appeals on weighted deduction were rejected, while the Revenue's appeals on MEIS receipts, MAT adjustment, and subsidiary-investment loss were rejected, leaving the appellate order substantially intact with mixed results overall.

Ratio Decidendi: After the statutory amendment to section 35(2AB), deduction is restricted to the expenditure quantified by the prescribed authority, whereas export incentive receipts and losses on subsidiary investments, when established as capital receipt or business loss on commercial expediency, are to be treated according to their true legal character and not merely by their accounting treatment.

---